Pelthos Therapeutics (PTHS) Earnings Date & Reports

Pelthos Therapeutics Inc is a biopharmaceutical company committed to commercializing safe and efficacious therapeutic products to help patients with unmet treatment burdens... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

PTHS is expected to report earnings to fall 95.62% to -28 cents per share on November 12

Pelthos Therapeutics PTHS Stock Earnings Reports

Q3'26

Est.

$-0.29

Q2'26

Missed

by $6.11

Q1'26

Missed

by $2.58

Q4'25

Missed

by $6.33

The last earnings report on August 13 showed earnings per share of -661 cents, missing the estimate of -50 cents. With 10.09K shares outstanding, the current market capitalization sits at 81.35M.

View a ticker or compare two or three

PTHS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for PTHS